Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc.

Tango Therapeutics is a biotech company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. Startup focuses on three areas of drug development which includes: loss of tumor suppressor gene function; multiple oncogenic drivers; and immune evasion.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.tangotx.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address
11 Hurley Street, MA, 02141
Cambridge
United States
Email
Contact Number
+1-857-320-4900

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/tango-therapeutics” connections=”true” suffix=””]

Tango Therapeutics has established a robust product engine that leverages advances in DNA sequencing and CRISPR-based target discovery to generate breakthrough medicines that have the potential to provide deeper, more sustained benefit than todays targeted therapies, and extend the benefit of available immuno-oncology agents.

Tango was launched in 2017 with a $55 million Series A investment from Third Rock Ventures.